Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibition of adriamycin-stimulated microsomal lipid peroxidation by mitoxantrone and ametantrone, two new anthracenedione antineoplastic agents.

× No keyword cloud information.

7 in total

1. Overadditive synergism between the intercalators mitoxantrone and lucanthone in advanced L 12010 and P 388 leukemia.

Authors: H Osswald; M Youssef
Journal: J Cancer Res Clin Oncol Date: 1986 Impact factor: 4.553

2. Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer.

Authors: M Bontenbal; A S Planting; C J Rodenburg; A Dees; J Verweij; C C Bartels; J Alexieva-Figusch; W L van Putten; J G Klijn
Journal: Breast Cancer Res Treat Date: 1992 Impact factor: 4.872

Review 3. Pharmacokinetics and metabolism of mitoxantrone. A review.

Authors: G Ehninger; U Schuler; B Proksch; K P Zeller; J Blanz
Journal: Clin Pharmacokinet Date: 1990-05 Impact factor: 6.447

Review 4. Are reduced quinones necessarily involved in the antitumour activity of quinone drugs?

Authors: J Butler; B M Hoey
Journal: Br J Cancer Suppl Date: 1987-06

5. Development of mitoxantrone.

Authors: R J White; F E Durr
Journal: Invest New Drugs Date: 1985 Impact factor: 3.850

6. Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, CI941 and ametantrone in MCF-7 cells: comparison with doxorubicin.

Authors: G R Fisher; L H Patterson
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

7. Mitoxantrone: propensity for free radical formation and lipid peroxidation--implications for cardiotoxicity.

Authors: R F Novak; E D Kharasch
Journal: Invest New Drugs Date: 1985 Impact factor: 3.850

7 in total